NCT03992248

Brief Summary

Modern life is characterized by a 24-hour lifestyle in which food intake is no longer restricted to daytime. As a result, people nowadays tend to eat throughout the day. When food is being consumed the energy is both used and stored for later use. Eating for a prolonged period of time makes it unnecessary for the body to use its energy storage. It is hypothesized that the decreased use of energy stores has detrimental effects on our sugar balance, mainly on insulin sensitivity. Conversely, eating within a limited period during the day could improve insulin sensitivity in people with type 2 diabetes by an increased use of energy reserves, specifically liver sugar stores. Therefore, this study examines the effect of eating within a limited time frame during the day on insulin sensitivity and liver sugar stores of people with type 2 diabetes.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
21

participants targeted

Target at below P25 for not_applicable type-2-diabetes-mellitus

Timeline
Completed

Started Jan 2019

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 31, 2019

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

June 18, 2019

Completed
2 days until next milestone

First Posted

Study publicly available on registry

June 20, 2019

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 3, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 3, 2021

Completed
Last Updated

February 9, 2021

Status Verified

February 1, 2021

Enrollment Period

2 years

First QC Date

June 18, 2019

Last Update Submit

February 8, 2021

Conditions

Keywords

TRFHepatic glycogenType 2 diabetesInsulin sensitivity

Outcome Measures

Primary Outcomes (1)

  • Hepatic glycogen

    13C-Magnetic Resonance Spectrometry

    Measurement performed after 3 weeks of intervention/control

Secondary Outcomes (1)

  • Insulin sensitivity

    Measurement performed after 3 weeks of intervention/control

Study Arms (2)

Time Restricted Feeding

EXPERIMENTAL

Participants are instructed to eat within a limited time frame during the day. They are also instructed to keep record of their eating and sleeping record with eat- and sleep diaries.

Behavioral: Time restricted feeding

Control

OTHER

Participants are instructed to spread their habitual food intake over at least 14hrs per day. They are also instructed to keep record of their eating and sleeping record with eat- and sleep diaries.

Behavioral: Control

Interventions

Eating within a time frame of 10hrs during the day. Outside of this time frame, participants need to refrain from food and energy containing drinks.

Time Restricted Feeding
ControlBEHAVIORAL

Eating for at least 14hrs per day.

Control

Eligibility Criteria

Age50 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Signed informed consent
  • Caucasian
  • Non-insulin treated type 2 diabetes,
  • BMI: \>25 kg/m2
  • Regular sleeping time (normally 7 - 9 hrs daily)
  • Habitual bedtime at 11 PM plus/minus 2 hours

You may not qualify if:

  • Not being able to adhere to a restricted feeding schedule
  • Uncontrolled hypertension
  • Active cardiovascular disease
  • Insulin therapy
  • Use of SGLT2 inhibitors
  • BMI\>38 kg/m2
  • Engaged in programmed exercise for \>3hrs per week
  • Extreme early bird or extreme night person
  • Heavily varying sleep-wake rhythm
  • Shiftwork during last 3 months
  • Smoking
  • Contra-indication to MRI scanning
  • Subjects who intend to donate blood during the intervention or subjects who have donated blood less than three months before the start of the intervention
  • Subjects who do not want to be informed about unexpected medical findings during the screening/study, or do not wish that their physician is informed
  • Unstable body weight (weight gain or loss \>3kg in the last 3 months)
  • +3 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Maastricht University

Maastricht, Limburg, 6229ER, Netherlands

Location

Related Publications (1)

  • Andriessen C, Fealy CE, Veelen A, van Beek SMM, Roumans KHM, Connell NJ, Mevenkamp J, Moonen-Kornips E, Havekes B, Schrauwen-Hinderling VB, Hoeks J, Schrauwen P. Three weeks of time-restricted eating improves glucose homeostasis in adults with type 2 diabetes but does not improve insulin sensitivity: a randomised crossover trial. Diabetologia. 2022 Oct;65(10):1710-1720. doi: 10.1007/s00125-022-05752-z. Epub 2022 Jul 25.

MeSH Terms

Conditions

Diabetes Mellitus, Type 2Insulin Resistance

Condition Hierarchy (Ancestors)

Diabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System DiseasesHyperinsulinism

Study Officials

  • Patrick Schrauwen, Prof. Dr.

    Maastricht University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
Due to the nature of this study, it is not possible to mask the intervention effect for the investigator or the participant. During randomisation, the intervention arms will be coded with 1 and 2 and the independent researcher will be unaware which intervention is assigned to which letter. With this approach, concealed allocation will be guaranteed. Additionally, the person in charge with the data quality check and the data analyses will be blinded for the interventions using this same randomisation codes to generate unbiased results.
Purpose
TREATMENT
Intervention Model
CROSSOVER
Model Details: Randomised controlled cross-over design with two 3-week arms and a 4-week wash-out period.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 18, 2019

First Posted

June 20, 2019

Study Start

January 31, 2019

Primary Completion

February 3, 2021

Study Completion

February 3, 2021

Last Updated

February 9, 2021

Record last verified: 2021-02

Locations